U.S. CDC advisers back Moderna COVID vaccine for teens, older children

Advisors to the U.S. Centers for Disease Control and Prevention (CDC) voted unanimously on Thursday to recommend the use of Moderna Inc.’s COVID-19 vaccine for children and adolescents ages 6 to 17. CDC director Rochelle Walensky is expected to sign the recommendations soon, allowing the US government to begin rolling out the Moderna vaccine for these age groups.

That would mean both mRNA COVID vaccines would be available to all Americans 6 months and older. The Pfizer-BioNTech vaccine, based on similar messenger RNA technology, has been available to teens and children ages 5-11 for over a year since October.

About 25 million U.S. children and adolescents in that age group have yet to receive one dose of a COVID-19 vaccine, CDC official Sara Oliver told the expert advisory panel. There is concern that the Moderna vaccine, which is given at a higher dose than the Pfizer/BioNTech injection, may cause types of heart inflammation more quickly, especially in younger men.

The agency said last week that more recent U.S. data showed that while there was a numerically higher rate of myocarditis or pericarditis with Moderna’s injection, the findings were not statistically significant, meaning they could be due to chance. The FDA last week approved Moderna’s vaccine for the 6-11 age group, along with approval for use in children 6 months to 5 years old.

(This story has not been edited by Devdiscourse staff and is automatically generated from a syndicated feed.)

Leave a Comment

Your email address will not be published.